Contact Us  
Home  |  About Us   |  Investor Services   
Closed Issues
Asston Pharmaceuticals Ltd.
09-Jul-25  
11-Jul-25  
100  
 
115 - 123  
2000  
1606000  
1  
Objective
1. Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit;2. Funding the incremental working capital requirements of our Company;3. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by ourCompany; and4. General Corporate Purposes
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For    
Non-Institutional Investors   435000   113826000   261.668965517241  
Qualified Institutional Buyers   425000   36449000   85.7623529411765  
Retail Individual Investors   746000   128410000   172.131367292225  
Business Description
Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products indomestic and various African ...
Promoter's Holding
4331680  
1606000  
69.07  
 
 
Address
Registrar
Listed at
Lead Manager
Promoters